Follow
Mario Eisenberger
Mario Eisenberger
Professor of Oncology,Johns Hopkins University
Verified email at jhmi.edu
Title
Cited by
Cited by
Year
Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer
IF Tannock, R De Wit, WR Berry, J Horti, A Pluzanska, KN Chi, S Oudard, ...
New England Journal of Medicine 351 (15), 1502-1512, 2004
66232004
Mortality results from a randomized prostate-cancer screening trial
GL Andriole, ED Crawford, RL Grubb III, SS Buys, D Chia, TR Church, ...
New England journal of medicine 360 (13), 1310-1319, 2009
37022009
Natural history of progression after PSA elevation following radical prostatectomy
CR Pound, AW Partin, MA Eisenberger, DW Chan, JD Pearson, PC Walsh
Jama 281 (17), 1591-1597, 1999
35181999
AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer
ES Antonarakis, C Lu, H Wang, B Luber, M Nakazawa, JC Roeser, ...
New England Journal of Medicine 371 (11), 1028-1038, 2014
23802014
Chemohormonal therapy in metastatic hormone-sensitive prostate cancer
CJ Sweeney, YH Chen, M Carducci, G Liu, DF Jarrard, M Eisenberger, ...
New England Journal of Medicine 373 (8), 737-746, 2015
22562015
Design and end points of clinical trials for patients with progressive prostate cancer and castrate levels of testosterone: recommendations of the Prostate Cancer Clinical …
HI Scher, S Halabi, I Tannock, M Morris, CN Sternberg, MA Carducci, ...
Journal of clinical oncology: official journal of the American Society of …, 2008
21842008
A controlled trial of leuprolide with and without flutamide in prostatic carcinoma
ED Crawford, MA Eisenberger, DG McLeod, JT Spaulding, R Benson, ...
New England Journal of Medicine 321 (7), 419-424, 1989
18231989
Risk of prostate cancer–specific mortality following biochemical recurrence after radical prostatectomy
SJ Freedland, EB Humphreys, LA Mangold, M Eisenberger, FJ Dorey, ...
Jama 294 (4), 433-439, 2005
14802005
Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer: updated survival in the TAX 327 study
DR Berthold, GR Pond, F Soban, R De Wit, M Eisenberger, IF Tannock
Journal of Clinical Oncology 26 (2), 242-245, 2008
13532008
Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer: updated survival in the TAX 327 study
DR Berthold, GR Pond, F Soban, R De Wit, M Eisenberger, IF Tannock
Journal of Clinical Oncology 26 (2), 242-245, 2008
13532008
Eligibility and response guidelines for phase II clinical trials in androgen-independent prostate cancer: recommendations from the Prostate-Specific Antigen Working Group
GJ Bubley, M Carducci, W Dahut, N Dawson, D Daliani, M Eisenberger, ...
Journal of Clinical Oncology 17 (11), 3461-3467, 1999
11111999
Bilateral orchiectomy with or without flutamide for metastatic prostate cancer
MA Eisenberger, BA Blumenstein, ED Crawford, G Miller, DG McLeod, ...
New England Journal of Medicine 339 (15), 1036-1042, 1998
10951998
Identification of endothelin–1 in the pathophysiology of metastatic adenocarcinoma of the prostate
JB Nelson, SP Hedican, DJ George, AH Reddi, S Piantadosi, ...
Nature medicine 1 (9), 944-949, 1995
7411995
Copy number analysis indicates monoclonal origin of lethal metastatic prostate cancer
W Liu, S Laitinen, S Khan, M Vihinen, J Kowalski, G Yu, L Chen, ...
Nature medicine 15 (5), 559-565, 2009
6902009
NCCN Practice Guidelines for Cancer-Related Fatigue.
V Mock, A Atkinson, A Barsevick, D Cella, B Cimprich, C Cleeland, ...
Oncology (Williston Park, NY) 14 (11A), 151-161, 2000
6532000
Androgen receptor splice variant 7 and efficacy of taxane chemotherapy in patients with metastatic castration-resistant prostate cancer
ES Antonarakis, C Lu, B Luber, H Wang, Y Chen, M Nakazawa, R Nadal, ...
JAMA oncology 1 (5), 582-591, 2015
6102015
Chemohormonal therapy in metastatic hormone-sensitive prostate cancer: long-term survival analysis of the randomized phase III E3805 CHAARTED trial
CE Kyriakopoulos, YH Chen, MA Carducci, G Liu, DF Jarrard, NM Hahn, ...
Journal of Clinical Oncology 36 (11), 1080, 2018
5822018
Cancer-related fatigue, version 2.2015
AM Berger, K Mooney, A Alvarez-Perez, WS Breitbart, KM Carpenter, ...
Journal of the National Comprehensive Cancer Network 13 (8), 1012-1039, 2015
5802015
Outcomes of observation vs stereotactic ablative radiation for oligometastatic prostate cancer: the ORIOLE phase 2 randomized clinical trial
R Phillips, WY Shi, M Deek, N Radwan, SJ Lim, ES Antonarakis, SP Rowe, ...
JAMA oncology 6 (5), 650-659, 2020
4352020
A contemporary prognostic nomogram for men with hormone-refractory metastatic prostate cancer: a TAX327 study analysis
AJ Armstrong, ES Garrett-Mayer, YCO Yang, R De Wit, IF Tannock, ...
Clinical Cancer Research 13 (21), 6396-6403, 2007
3992007
The system can't perform the operation now. Try again later.
Articles 1–20